Pharmidex Pharmaceutical Services Limited is a registered limited company operating within the UK, established in 2002 and currently active. The company specializes in providing specialized research and development services to pharmaceutical and biotechnology companies. Pharmidex focuses primarily on the critical stages of drug development, offering expertise across multiple therapeutic areas. Their core services encompass preclinical research, including DMPK (Drug Metabolism and Pharmacokinetics) studies, and analytical method development. The company’s expertise extends to CNS (Central Nervous System) drug development, oncology drug discovery, respiratory disease research, and formulation development. Pharmidex also provides support in ADMET/pharmacokinetics, a crucial aspect of drug candidate assessment. Strategically located at 167-169 Great Portland Street, London, W1W 5PF, Pharmidex serves a diverse client base both domestically and internationally. The company employs a team of skilled scientists and technicians, indicating a commitment to delivering high-quality, tailored solutions. As a Skilled Worker with a Worker rating, Pharmidex is actively seeking to expand its capabilities and client relationships. The company’s SIC codes include: - 72110: Research and experimental development on biotechnology, - 6411: Pharmaceutical research and development, - 6412: Pharmaceutical formulation and development.

Pharmidex Pharmaceutical Services Limited is a registered limited company operating within the UK, established in 2002 and currently active. The company specializes in providing specialized research and development services to pharmaceutical and biotechnology companies. Pharmidex focuses primarily on the critical stages of drug development, offering expertise across multiple therapeutic areas. Their core services encompass preclinical research, including DMPK (Drug Metabolism and Pharmacokinetics) studies, and analytical method development. The company’s expertise extends to CNS (Central Nervous System) drug development, oncology drug discovery, respiratory disease research, and formulation development. Pharmidex also provides support in ADMET/pharmacokinetics, a crucial aspect of drug candidate assessment. Strategically located at 167-169 Great Portland Street, London, W1W 5PF, Pharmidex serves a diverse client base both domestically and internationally. The company employs a team of skilled scientists and technicians, indicating a commitment to delivering high-quality, tailored solutions. As a Skilled Worker with a Worker rating, Pharmidex is actively seeking to expand its capabilities and client relationships. The company’s SIC codes include: - 72110: Research and experimental development on biotechnology, - 6411: Pharmaceutical research and development, - 6412: Pharmaceutical formulation and development.